Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2007
09/13/2007US20070213299 pyridinium salts such as 1-ethyl-(E,E)-2,6-bis[2-[4-(dimethylamino)phenyl]ethenyl]pyridinium chloride, used as fungicides, bactericides or insecticides on a substrate ( lumber, decking, flooring, roofing, carpets, wallpaper, paneling, cloth caulking etc.); encapsulated, sustained release
09/13/2007US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070212297 Amino methyl imidazoles and related compounds as C5a receptor modulators
09/13/2007CA2644850A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
09/13/2007CA2644672A1 Quinazoline derivatives as phosphodiesterase 10 inhibitors
09/13/2007CA2644280A1 Phosphodiesterase 10 inhibitors
09/13/2007CA2642870A1 Improved prodrugs of cc-1065 analogs
09/13/2007CA2642436A1 New amines
09/12/2007EP1831201A1 Piperidine and azetidine derivatives as glyt1 inhibitors
09/12/2007EP1831200A2 Novel farnesyl protein transferase inhibitors as antitumor agents
09/12/2007EP1831199A1 Novel compounds
09/12/2007EP1831198A1 Pyridine carboxamide derivatives for use as anticancer agents
09/12/2007EP1831197A2 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
09/12/2007EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors
09/12/2007EP1831195A1 5-ht7 receptor antagonists
09/12/2007EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY
09/12/2007EP1831193A1 Imidazole derivatives
09/12/2007EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
09/12/2007EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
09/12/2007EP1831183A1 1,6-substituted (3r,6r)-3-(2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis
09/12/2007EP1831174A1 Amide derivatives
09/12/2007EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders
09/12/2007EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases.
09/12/2007EP1831164A1 Heterocyclic compounds as ccr2b antagonists
09/12/2007EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
09/12/2007EP1830852A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
09/12/2007EP1830841A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
09/12/2007EP1830840A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
09/12/2007EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/12/2007EP1682528B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES
09/12/2007EP1613304B1 Dpp-iv inhibitors
09/12/2007EP1562932B9 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
09/12/2007EP1558580B1 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
09/12/2007EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
09/12/2007EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/12/2007EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
09/12/2007EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
09/12/2007EP1303496B1 Pyrimidine derivatives
09/12/2007EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/12/2007EP1253149B1 Sulfate salt of quinolonecarboxylic acid derivative and use thereof
09/12/2007CN101035785A Novel compounds having an anti-bacterial activity
09/12/2007CN101035783A Urea derivatives as calcium channel blockers
09/12/2007CN101035780A Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
09/12/2007CN101035769A Pyrimidine urea derivatives as kinase inhibitors
09/12/2007CN101035768A Compounds and compositions useful as cathepsin S inhibitors
09/12/2007CN101035766A 3-(2-hydroxyphenyl) pyrazoles and their use as HSP90 modulators
09/12/2007CN101035762A Alkil-pyridines as 11-beta inhibitors for diabetes
09/12/2007CN101035761A 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt
09/12/2007CN101035755A Method of deprotection
09/12/2007CN101035534A Amino substituted aryloxybenzylpiperidine derivatives
09/12/2007CN101035525A Substituted urea derivatives for treating cardiac diseases
09/12/2007CN101033224A Novel pyrimidines small molecular compound, its preparation method and use
09/12/2007CN101033223A Argatroban byproduct and its synthesis, separation and identification method
09/11/2007US7268232 Androgen receptor modulators and method of treating disease using the same
09/11/2007US7268230 Quinazoline compounds
09/11/2007US7268158 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
09/11/2007US7268157 Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/11/2007US7268154 Substituted triazole compounds
09/11/2007US7268151 2-[4-(3-Methoxy-4-pyridin-2-ylphenyl)-2H-1,2,3-triazol-2-yl]pyridine; psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders
09/11/2007US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt
09/11/2007US7268142 4-chloro-N-[2-(6,7-dimethoxy-quinazolin-4-yl)-1,2,3,4-tetrahydro-isoquinolin-7-yl]-benzenesulfonamide; schizophrenia, central nervous system disorders
09/11/2007US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES
09/11/2007US7268134 Medical devices employing triazine compounds and compositions thereof
09/11/2007US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
09/11/2007CA2394439C Process for the preparation of a pyridinemethanol compound
09/11/2007CA2318368C Novel tricyclic compound
09/11/2007CA2257846C Process for preparing imidazoquinolinamines
09/07/2007WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
09/07/2007WO2007100852A1 Therapeutic piperazines as pde4 inhibitors
09/07/2007WO2007100851A1 Therapeutic compounds
09/07/2007WO2007100739A1 Ccr5 antagonists useful for treating hiv
09/07/2007WO2007100646A1 Multi-cyclic compounds and method of use
09/07/2007WO2007100282A1 New salts of an indole derivative and their use in medicine
09/07/2007WO2007100066A1 17β HSD type 5 INHIBITOR
09/07/2007WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
09/07/2007WO2007099385A1 Dipeptidyl peptidase iv inhibitor compounds and compositions
09/07/2007WO2007099335A1 Quinoline derivatives for treating cancer
09/07/2007WO2007099326A1 Quinoline derivatives
09/07/2007WO2007099317A1 Quinazoline derivatives
09/07/2007WO2007098962A1 Sigma receptor compounds
09/07/2007WO2007098953A1 Pyrazole derivatives as sigma receptor inhibitors
09/07/2007WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
09/07/2007WO2007084532A3 Combination therapy with parp inhibitors
09/07/2007WO2007075688A3 Substituted aniline derivatives useful as histamine h3 antagonists
09/07/2007WO2007060144A3 Novel quinoxaline derivatives and their medical use
09/07/2007WO2007011760A3 Inhibitors of mitotic kinesin
09/07/2007WO2006042034A8 Salt and crystalline forms thereof of a drug
09/07/2007WO2006041888A3 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
09/07/2007CA2644809A1 17 .beta. hsd type 5 inhibitor
09/07/2007CA2644069A1 Therapeutic piperazines as pde4 inhibitors
09/07/2007CA2644068A1 Therapeutic compounds
09/07/2007CA2643323A1 Ccr5 antagonists useful for treating hiv
09/07/2007CA2643044A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
09/07/2007CA2642973A1 Quinoline derivatives
09/07/2007CA2642813A1 Inhibitors of histone deacetylase
09/07/2007CA2642424A1 Primary amines as renin inhibitors
09/07/2007CA2641145A1 Sigma receptor compounds
09/07/2007CA2641144A1 Pyrazole derivatives as sigma receptor inhibitors
09/07/2007CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
09/06/2007US20070208176 Biphenyl derivatives
1 ... 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 ... 1080